Administrative & Regulatory Law · European Union
Clear the Path to Market With a Pharmaceutical Law Specialist
Marketing authorisations, clinical trials, pricing, advertising and pharmacovigilance are governed by exacting EU and national rules — and a single compliance gap can delay a product or trigger regulatory action. We match you, free of charge, with a lawyer who handles pharmaceutical law across Europe every day.
- Authorisation, pricing & compliance expertise
- Lawyers across the EU & EEA
- No fee to get matched
No commitment. No hidden fees.
Get matched with a lawyer
Tell us about your situation and receive a free, confidential case review.
Who this is for
For manufacturers, biotech firms, distributors and anyone bringing medicines to the European market
Pharmaceutical law is the legal framework that governs medicines from research through to sale — marketing authorisation, clinical trials, manufacturing and distribution standards, pricing and reimbursement, advertising to professionals and the public, and the pharmacovigilance duties that continue after launch. In Europe the rules are layered: some are set centrally through EU procedures, while pricing, reimbursement and much of the day-to-day enforcement remain firmly national, so the same product can face very different requirements from one country to the next. The consequences of getting it wrong are serious — delayed approvals, interrupted supply, withdrawn products and regulatory penalties. Whether you are seeking a first authorisation, expanding into new markets or responding to an inspection, a specialist who knows both the EU framework and the relevant national systems is essential to move quickly and stay compliant.
Why companies get stuck
Medicines stall at the regulatory gate, not the laboratory.
The obstacle is usually procedural.
Authorisation routes and national requirements differ by product and by country, and they shift as regulations evolve.
Choosing the wrong authorisation route
Centralised, mutual-recognition and decentralised procedures each suit different products, and national rules overlay them. Picking the wrong route can add months to a launch or leave a filing invalid in the markets that matter most.
Pricing and reimbursement hurdles
Getting a product authorised is only half the battle — in most countries it must also clear national pricing and reimbursement assessments. These processes are complex, political and vary widely, and a poorly prepared dossier can stall market access.
Post-market obligations
Pharmacovigilance, variations, renewals and advertising rules continue for the entire life of a medicine. A missed report or an off-label promotion issue can draw serious regulatory scrutiny long after a successful launch.
What you get
A pharmaceutical law lawyer who understands both the EU and national systems
We only match you with regulatory lawyers who work in the life sciences on a regular basis.
Regulatory strategy
Your lawyer maps the most efficient authorisation route for your product across your target countries — centralised, mutual recognition or national — and flags the requirements that will actually determine your timeline.
Pricing & market access
Practical support on national pricing and reimbursement submissions, so your filing addresses the criteria the assessment bodies care about and gives your product its best chance of access.
Lifecycle compliance
Ongoing help with variations, renewals, advertising, and pharmacovigilance duties, keeping your product compliant for its entire life on the market rather than just at launch.
Inspection & enforcement
If an inspection, warning letter or enforcement action lands, you get a lawyer who knows how to respond, correct the underlying issue and defend your position before the relevant authority.
Coverage
Pharmaceutical law lawyers across Europe
Authorisation can be centralised, but pricing, reimbursement and enforcement remain national. We match cases across the following countries and beyond:
Frequently asked
Pharmaceutical law — common questions
What is pharmaceutical law?
Pharmaceutical law is the legal framework governing medicines across their lifecycle — clinical trials, marketing authorisation, manufacturing and distribution, pricing and reimbursement, advertising and pharmacovigilance. In Europe it combines EU-level procedures with national rules that differ from country to country.
What is the difference between centralised and national authorisation?
Centralised authorisation is granted through a single EU procedure and applies across the Union, and is mandatory for certain product categories. Other medicines may follow mutual-recognition or national routes. The best route depends on your product and target markets, so a specialist should advise on the right choice.
How do pricing and reimbursement work?
Pricing and reimbursement are decided at national level in most European countries, independently of marketing authorisation. Each country runs its own assessment process, and the rules differ widely. A lawyer familiar with the relevant national systems can help you prepare a filing that meets their specific criteria.
What is pharmacovigilance?
Pharmacovigilance is the ongoing duty to monitor, record and report the safety of a medicine after it is on the market. Companies must run robust systems to collect adverse event reports and act on signals, and failing to do so can draw serious regulatory action.
Can a medicine be promoted directly to patients?
In the EU, prescription medicines generally may not be advertised to the public, though advertising to healthcare professionals is permitted within strict limits. The rules vary by country and product type, so promotional material should be reviewed by a lawyer before use.
What happens if we fail an inspection?
An inspection finding does not usually end a product’s life. The response typically involves correcting the underlying issue and demonstrating the fix to the authority, and the exact process depends on the country and the severity of the finding. A lawyer experienced in inspections can guide you through it.
Free case review
Bring your medicine to market the right way
Tell us about your product and target markets, and we’ll connect you with a pharmaceutical law lawyer who handles cases like yours — free of charge, with no obligation to hire.